Essential Drug Classes

The exam loves the muscle/kidney follow-up: a patient reports new muscle aches, dark or “tea-colored” urine, and weakness — the priority is to hold the dose and notify the provider for a creatine kinase (CK), because that picture suggests rhabdomyolysis, not a benign ache. A second favorite is timing and food: counsel patients to avoid large amounts of grapefruit juice, which inhibits CYP3A4 and can raise drug levels. Atorvastatin’s long half-life lets it be taken any time of day, unlike short-acting agents (simvastatin, lovastatin) dosed at bedtime. For childbearing-age patients, note the FDA removed the blanket pregnancy contraindication in 2021, but statins are still stopped in most pregnancies — a high-yield distractor. (Some older question banks still label statins pregnancy “Category X” / absolutely contraindicated.)

The classic trap is lumping atorvastatin with metoprolol and lisinopril as “the heart drugs.” Only atorvastatin targets cholesterol, so a falling LDL — not a falling pulse or blood pressure — confirms it is working. Don’t apply the apical-pulse hold (metoprolol) or the dry cough/hyperkalemia warning (lisinopril) here.

Exam items lean on the iodinated-contrast scenario: the “tell” is a client on metformin headed for a CT with dye or a cardiac cath. The hinge is renal function plus route — current ACR guidance says a client with normal renal function getting IV contrast usually needs no hold, but with reduced renal function, AKI, or arterial/catheter studies (cardiac cath), hold metformin at the procedure and for 48 hours, then resume only after renal function is rechecked and normal. The dreaded answer is the rare but lethal lactic acidosis: report myalgias, unusual somnolence, unexplained hyperventilation, and abdominal distress — vague symptoms test-writers love to disguise.

The classic trap is confusing it with insulin: metformin alone essentially does not cause hypoglycemia, so “give juice/15 g carbs” is wrong unless a sulfonylurea or insulin is also on board. Don’t expect peak/onset timing here — that’s an insulin distinction. Two sleepers: chronic metformin use can cause vitamin B12 deficiency, and it is withheld in acutely ill clients (sepsis, dehydration, hypoxia) where lactic-acidosis risk climbs.

The exam loves the timing and lab-interval question: TSH is rechecked roughly 6–8 weeks after any dose change, so a stem about a patient who “feels no better after one week” is testing whether you’ll wrongly escalate — the right answer is reassure and wait, because the full effect takes weeks. Watch for over-replacement tells: tachycardia, palpitations, weight loss, heat intolerance, insomnia, and tremor mean the dose is too high (signs of hyperthyroidism/thyrotoxicosis), and a resting heart rate over 100 or new chest pain is a classic cue to hold and notify the provider. In older adults or cardiac patients, expect “start low, go slow” to avoid precipitating angina or arrhythmia.

Classic traps: don’t confuse the under-replaced patient (fatigue, cold intolerance, constipation, weight gain → raise the dose) with toxicity. Mind absorption pitfalls — separate from calcium, iron, and antacids by ~4 hours (PPIs may also blunt uptake, though the effect is less consistent). Memory hook: “T4 = TSH check, Take on an empty stomach, Tachycardia = too much.”

Expect the exam to hand you a post-dose assessment rather than a definition: after a treatment the patient’s heart rate jumps, hands shake, or potassium drops — these are expected beta-2 effects (tachycardia, tremor, palpitations) plus hypokalemia from intracellular potassium shift, not an allergic reaction, so the answer is to reassess and continue, not stop. When a question stacks albuterol with an inhaled corticosteroid, the tested principle is sequence and rinse: give albuterol first to open the airways, wait, then the steroid; rinsing after the steroid prevents oral thrush, a detail that has nothing to do with albuterol.

The classic trap pairs albuterol with metoprolol — even a “cardioselective” beta-blocker can blunt rescue bronchodilation, so flag that combination. Don’t confuse the quick-relief rescue role with prednisone’s slow anti-inflammatory treatment of a severe flare, which takes hours; albuterol relieves bronchospasm in about 5 minutes but treats no inflammation. Memory hook: albuterol = the fire extinguisher (rescue now), steroids = the smoke detector (prevent the fire).

Expect NCLEX to test timing and onset: PPI effect is cumulative, so full acid suppression takes several consecutive daily doses (roughly 1–4 days) — a patient expecting instant relief is the teaching cue, and the exam wants an antacid or H2 blocker like famotidine for breakthrough symptoms, not a second PPI dose. The other favorite is clopidogrel: omeprazole inhibits CYP2C19, blunting clopidogrel’s antiplatelet activation, so the answer is to question that combination or switch to pantoprazole (less CYP2C19 effect). Long-term, the answer often hinges on serum magnesium, and new-onset diarrhea raises C. difficile.

The classic trap is confusing the “-prazole” PPIs with the “-tidine” H2 blockers — H2 blockers are weaker but faster, PPIs stronger but delayed. Students also assume PPIs are harmless long-term; flag fractures, hypomagnesemia, B12 deficiency, and rebound acid hypersecretion on abrupt discontinuation. Memory hook: “prazoles pump the brakes” on the proton pump.

The exam loves the “which assessment before you give it” stem, and the answer hinges on respiratory rate — the commonly taught rule is to hold the dose and notify the provider if RR is below 12/min (some protocols use 8–10, so follow facility policy). Note the trap: the safest action is to withhold the dose, not to give it and monitor afterward. Sedation level is the other priority parameter, because rising sedation precedes respiratory depression. In the pulmonary-edema scenario, also watch for hypotension. The overdose triad to recognize is pinpoint pupils, respiratory depression, and CNS depression (coma).

The sharpest contrast is with naloxone: morphine is the agonist that causes the depression; naloxone is the antagonist that reverses it. The classic miss is that naloxone’s short duration can outlast a single dose, so re-sedation can recur as it wears off — keep monitoring and be ready to redose. Don’t confuse opioid-induced respiratory depression (give naloxone) with benzodiazepine oversedation (give flumazenil). Memory hook: “morphine drops the rate, naloxone brings it back.”

On the exam, the trigger is the opioid toxidrome — abnormally slow breathing (often well under 12, sometimes 4–6/min) with pinpoint pupils and a depressed level of consciousness in someone on opioids. The answer almost always pairs naloxone with airway support and ventilation (open the airway, oxygenate/bag-valve-mask first or simultaneously), never naloxone alone. Titrate to adequate breathing, not full alertness, to avoid precipitating violent acute withdrawal. The high-yield “tell” afterward is re-narcotization: because many opioids outlast the antagonist, the right answer is to keep monitoring and re-dose.

The trap with morphine is reflexive reversal: a stable post-op patient who is drowsy but breathing adequately does NOT get naloxone — you hold the next opioid dose instead (reserve naloxone for severe sedation with inadequate respirations). Naloxone reverses opioids only; it does nothing for benzodiazepine sedation (flumazenil) or heparin bleeding (protamine) — don’t grab the wrong antagonist. Memory hook: “Narcan = Narcotics canceled,” but only briefly.

The exam rarely asks what prednisone is — it tests what you monitor and what you teach. The classic stem hands you a patient on chronic steroids who suddenly “ran out” or stopped, then presents hypotension, weakness, hypoglycemia, nausea, and abdominal pain: that is adrenal (Addisonian) crisis, and the priority is an IV hydrocortisone bolus plus IV fluids — not “restart the oral dose.” A second high-yield pattern is the masked infection: steroids blunt the inflammatory response, so fever and WBC become unreliable signs — a serious infection may show only a low-grade temperature — so teach patients to report any sign of illness early.

Classic traps: students give the dose at bedtime, but steroids belong in the morning with food to mimic the natural cortisol peak and ease stomach irritation. Don’t confuse the hyperglycemia steroids cause with insulin’s hypoglycemia — a diabetic on prednisone usually needs more insulin. Mnemonic — the “S” hits: Sugar up, Sodium/fluid up, Skin thins, Sickness signs hidden.